美股A股
StockGist
Back
10-Q2026-05-05· deepseek-chat

PDYNW · Palladyne AI Corp.

0001193125-26-205042

SEC filing

Summary

Revenue more than doubled year-over-year, but operating losses widened sharply as the company invested heavily in AI/ML product commercialization and integrated recent acquisitions.

Key takeaways

Full analysis

Revenue Growth Driven by Acquisitions

Revenue for the first quarter of 2026 was $3.5 million, a 107% increase from $1.7 million in the prior-year period. The growth was primarily attributable to contributions from the November 2025 acquisitions of GuideTech, Warnke, and MKR, which expanded the company's customer base and service offerings.

Margin Compression Reflects Mix Shift

Operating Losses Widen on Investment Spending

Operating loss increased to $11.9 million from $6.9 million, driven by a more than doubling of research and development expenses and selling, general, and administrative expenses. The company is investing heavily in AI/ML product development, sales force expansion, and integration of recent acquisitions, which outpaced the revenue growth.

Net Income Swing Driven by Non-Operating Items

Cash Burn Continues; Balance Sheet Provides Runway

Net cash used in operating activities was $10.2 million, compared to $7.5 million in the prior year, reflecting increased spending on development and commercialization. Capital expenditures were minimal at $27,000, resulting in free cash flow of -$10.3 million. The company's cash and marketable securities balance, along with access to capital markets, is expected to fund operations for the foreseeable future, though management cautions that cash usage will be significantly affected by customer demand.

Outlook and Risks

Management expects losses and negative cash flow to continue as it scales product development and sales. Key risks include the uncertain adoption of AI/ML products, long sales cycles, integration of recent acquisitions, and potential supply chain disruptions. The company also faces cybersecurity, regulatory, and intellectual property risks, as detailed in its risk factors. The deSPAC warrants expire in September 2026, and if not exercised, they will expire worthless, but any exercise would further dilute equity.